Covid-19, Cuban drug Nimotuzumab granted Health Registration in Indonesia

The monoclonal antibody Nimotuzumab has demonstrated, during several years of clinical trials, its efficacy in the treatment of patients with cancer, and more recently in the use for the therapy of severe forms of COVID-19

The monoclonal antibody CIMAher -known as Nimotuzumab, created by the Centre for Molecular Immunology (CIM)- was recently granted Health Registration in Indonesia

CIM, spreading the news through its Twitter account, detailed that the drug was registered in the Asian country through the joint venture InnoCIMAb, formed by Cuba and Singapore.

He then pointed out that the establishment of this important event means an increase in sales of this product in this country and another recognition of the quality of our science.

The monoclonal antibody Nimotuzumab has demonstrated during several years of clinical trials its efficacy in the care of patients with cancer and more recently in the use for the therapy of severe forms of COVID-19

In 2002, it was granted medical registration for the treatment of advanced head and neck cancer and is currently used as a therapy for nasopharyngeal, oesophageal, pancreatic and lung cancer with non-small cell cancers.

It is registered in several countries and has special marketing permission in 15 territories in Europe and other countries, including Singapore.

Read Also:

Emergency Live Even More…Live: Download The New Free App Of Your Newspaper For IOS And Android

Cuba, Covid Soberana 02 And Abdala Vaccines Also Effective Against Omicron In 90% Of Cases

Omicron Variant: What Is It And What Are The Symptoms Of The Infection?

What Heart And Stroke Patients Need To Know About COVID-19 In 2022

Russia, Doctors Detect Mucormycosis In Covid-19 Patients: What Causes The Fungal Infection?

Covid, A Tale Of Two Years Of Pandemic Through Words

USA, Moderna To Request COVID Vaccine Authorization For Kids Under 6

Cuba, Unicef Donates Dexamethasone To Children’s Hospital: To Treat Covid Positive Patients

Covid Vaccine, Cuba To Start Trial Administration To 1.7 Million Inhabitants

Our Worlds In Data, Ranking The World’s Most Vaccinated Countries Against Covid: Saudi Arabia First, Cuba Second

Omicron 2, Contagiousness And Symptoms Of This Covid Variant

Covid, What To Know About The Omicron XE Variant

Omicron, Prof. Pregliasco Explains What To Expect From The New Covid Variant

Covid Omicron 5 Variant: Symptoms And Incubation

Source:

Granma

You might also like